Echo Therapeutics Inc fka ECTE

[ramad]

If that is your reasoning the price of the stock would be considerably higher if you had multiple bids to finance echo. Secondly, someone most likely the investor demanded the dismissel of the CEO if their were several other bidders to fund echo the CEO would not leave. Thirdly, echo's current CGM that MTIA was developing most likely does not meet the standards to go to clinical trials otherwise they would have started the trials. At this time they have no medical device. Echo has to demonstrate that their new version of their CGM will be competitive to the others that are on the market as to the accuracy of the readings of the glucose levels. To my knowledge echo does not have any prototype of the new model.They only have the components which they are testing as reported but has no fully assembled model. Thirdly, being MTIA and platinum at the present time own close or more than 36% of echo. It is hardly likely another large investor would step in not having much control in the direction of echo's future.